我们是为肿瘤检测提供分子产品和服务的最重要专家。 Invivoscribe 提供全方位的肿瘤学检测产品和服务(B 细胞和 T 细胞克隆性、NGS 基因组、MRD 检测和综合生物信息学软件),所有这些产品和服务均在 ISO 13485 设计控制下开发并在我们的 cGMP 设施中制造。 作为分子诊断领域的领先行业先驱,我们致力于提高全球医疗保健标准。 我们为临床实验室、制药公司、医生、患者和研究人员提供高质量、可靠和创新的分子诊断解决方案。这些解决方案的范围从 CDx 生物标志物识别和患者分层到检测开发和试剂制造,再到这些检测作为我们协调临床实验室的服务或作为可供 160 多个国家/地区的实验室使用的试剂盒的商业化。 我们努力解锁并提供个性化分子医学的全部潜力,因为我们知道每个人疾病背后的分子基础是不同的。 作为试剂制造商,我们为基因重排、染色体易位和基因突变检测提供全面的凝胶、毛细管和新一代测序 PCR 检测选择。这些产品可通过我们的全球分销网络获得,目前在 700 多个实验室中使用。 We are the foremost experts in providing molecular products and services for oncology testing. Invivoscribe offers a full range of oncology testing products and services (B- and T-cell clonality, NGS gene panels, MRD assays, and comprehensive bioinformatics software), all developed under ISO 13485 design control and manufactured in our cGMP facility. As a leading industry pioneer in the molecular diagnostic field, we are dedicated to improving the standard of healthcare worldwide. We offer clinical laboratories, pharmaceutical companies, physicians, patients, and researchers high quality, reliable, and innovative molecular diagnostic solutions. These solutions range from CDx biomarker identification and patient stratification to assay development and reagent manufacturing, to the commercialization of these assays either as services at our harmonized clinical laboratories or as kits available to laboratories in over 160 countries. We strive to unlock and make accessible, the full potential of personalized molecular medicine, as we know the molecular basis behind each person’s disease is different. As a reagent manufacturer, we offer a comprehensive selection of gel, capillary, and next-generation sequencing PCR assays for gene rearrangement, chromosome translocation, and gene mutation detection. These products are available through our global distribution network and are currently used in over 700 laboratories.